Home › Funds › Decheng Capital LLC › PYXS
Decheng Capital LLC position in PYXS
PYXIS ONCOLOGY INC · Health Care
Decheng Capital LLC reported holding 326,810 shares of PYXS (PYXIS ONCOLOGY INC) in its Q3 2026 13F filing — a position valued at US$761K, representing 0.11% of its reported portfolio and ranking #11 among its reported holdings. Decheng Capital LLC has disclosed PYXS holdings in 12 of the last 12 reported quarters, going back to Q4 2023.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How Decheng Capital LLC's PYXS position evolved
Decheng Capital LLC first disclosed a stake in PYXS in Q4 2023 at 326,810 shares (US$588K). The position peaked in Q1 2024 at 326,810 shares, worth US$1.4M. Across 12 filings, Decheng Capital LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 326,810 shares valued at US$761K.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 326.81K | $588.26K | New |
| Q1 2024 | 326.81K | $1.39M | Hold |
| Q2 2024 | 326.81K | $1.08M | Hold |
| Q3 2024 | 326.81K | $1.20M | Hold |
| Q4 2024 | 326.81K | $509.82K | Hold |
| Q1 2025 | 326.81K | $320.24K | Hold |
| Q2 2025 | 326.81K | $359.49K | Hold |
| Q3 2025 | 326.81K | $725.52K | Hold |
| Q4 2025 | 326.81K | $375.83K | Hold |
| Q1 2026 | 326.81K | $477.14K | Hold |
| Q2 2026 | 326.81K | $983.70K | Hold |
| Q3 2026 | 326.81K | $761.47K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About PYXS and 13F data
PYXS (PYXIS ONCOLOGY INC) is a Health Care company. 32 other funds we track also report a position in PYXS — the largest reported positions include GordonMD Global Investments LP (US$30.2M), PFIZER INC (US$20.1M), Laurion Capital Management LP (US$11.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding PYXS
- GordonMD Global Investments LP 10.02M sh · $30.17M · Q2 2026
- PFIZER INC 7.03M sh · $20.11M · Q3 2026
- Laurion Capital Management LP 4.99M sh · $11.63M · Q3 2026
- Palo Alto Investors LP 864.28K sh · $2.60M · Q2 2026
- Blue Owl Capital Holdings LP 1.00M sh · $2.33M · Q3 2026
- Stonepine Capital Management, LLC 689.00K sh · $1.61M · Q3 2026
- Atle Fund Management AB 663.77K sh · $1.55M · Q3 2026
- Monashee Investment Management LLC 229.31K sh · $534.29K · Q3 2026
More on Decheng Capital LLC
FAQ
How long has Decheng Capital LLC held PYXS?
Decheng Capital LLC has disclosed PYXS holdings in 12 of the last 12 reported quarters, going back to Q4 2023.
What is Decheng Capital LLC's current position in PYXS?
As of Q3 2026, Decheng Capital LLC holds 326.81K shares of PYXS (PYXIS ONCOLOGY INC), valued at $761.47K, representing 0.11% of its reported portfolio and ranking #11.
Has Decheng Capital LLC been buying or selling PYXS?
In the latest 13F filing (Q3 2026), Decheng Capital LLC held unchanged its position in PYXS. The position peaked in Q1 2024 at 326.81K shares.
Which other funds hold PYXS?
Other major institutional holders of PYXS include GordonMD Global Investments LP, PFIZER INC, Laurion Capital Management LP, among 32 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.